A detailed history of Logos Global Management LP transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 300,000 shares of PCVX stock, worth $25.8 Million. This represents 4.53% of its overall portfolio holdings.

Number of Shares
300,000
Holding current value
$25.8 Million
% of portfolio
4.53%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$70.52 - $117.12 $21.2 Million - $35.1 Million
300,000 New
300,000 $34.3 Million
Q1 2021

May 17, 2021

SELL
$18.66 - $29.16 $2.61 Million - $4.08 Million
-140,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$26.57 - $51.74 $3.72 Million - $7.24 Million
140,000 New
140,000 $3.72 Million
Q3 2020

Nov 16, 2020

SELL
$26.5 - $55.4 $12.1 Million - $25.2 Million
-455,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$26.15 - $35.45 $11.9 Million - $16.1 Million
455,000 New
455,000 $14.4 Million

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $5.1B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.